StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
6-factor scoring with sector-relative rank. Updated daily.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $1.93 | $1.94 | +0.52% | 0.0M |
| 05-12 | $1.91 | $1.99 | +4.14% | 0.0M |
| 05-13 | $1.96 | $1.89 | -3.57% | 0.0M |
| 05-14 | $1.85 | $1.91 | +3.24% | 0.0M |
| 05-15 | $1.92 | $1.81 | -5.73% | 0.0M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Annual 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $4.32K | $4.32K | $1.90K | $4.35K |
Operating Income | $-5.88M | $-3.95M | $-1.87M | $-8.35M |
Net Income | $-6.39M | $-4.41M | $-2.05M | $-8.77M |
EPS (Diluted) | $-2.61 | $-2.10 | $-1.58 | $-9.34 |
Total Assets | $7.55M | $6.00M | $6.44M | $4.22M |
Total Liabilities | $4.90M | $1.81M | $3.30M | $4.02M |
Cash & Equivalents | $3.40M | $1.95M | $2.79M | $1.10M |
Free Cash Flow OCF − CapEx | $-5.75M | $-4.30M | Not available | $-7.42M |
Shares Outstanding | 3.18M | 3.07M | 2.28M | 1.12M |
No sell-side coverage available for HSCS.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Fundamentals not available for HSCS.
No fundamental metrics available yet for this ticker — common for ETFs, foreign issuers without US listing depth, very recent IPOs, or thinly-traded OTC names. The Financials tab pulls from SEC EDGAR directly and may still have data.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.